De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
AtriCure Beheer
Beheer criteriumcontroles 2/4
De CEO AtriCure's is Mike Carrel, benoemd in Nov2012, heeft een ambtstermijn van 11.92 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 8.75M, bestaande uit 9.2% salaris en 90.8% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.36% van de aandelen van het bedrijf, ter waarde $ 18.53M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.7 jaar en 7.6 jaar.
Belangrijke informatie
Mike Carrel
Algemeen directeur
US$8.7m
Totale compensatie
| Percentage CEO-salaris | 9.2% |
| Dienstverband CEO | 11.9yrs |
| Eigendom CEO | 1.4% |
| Management gemiddelde ambtstermijn | 7.7yrs |
| Gemiddelde ambtstermijn bestuur | 7.6yrs |
Recente managementupdates
Recent updates
AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 43% Above Its Share Price
Oct 02
Further Upside For AtriCure, Inc. (NASDAQ:ATRC) Shares Could Introduce Price Risks After 29% Bounce
Sep 06Analysts Have Been Trimming Their AtriCure, Inc. (NASDAQ:ATRC) Price Target After Its Latest Report
Aug 02AtriCure's Latest Projects And European Market Entry, Advancing Cardiac Care
Jul 25AtriCure, Inc. (NASDAQ:ATRC) Soars 26% But It's A Story Of Risk Vs Reward
Jul 18AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 88% Above Its Share Price
May 30Positive Sentiment Still Eludes AtriCure, Inc. (NASDAQ:ATRC) Following 29% Share Price Slump
Apr 04Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?
Mar 14Investors Interested In AtriCure, Inc.'s (NASDAQ:ATRC) Revenues
Jan 21Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?
Nov 29AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price
Sep 27Health Check: How Prudently Does AtriCure (NASDAQ:ATRC) Use Debt?
Aug 02AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Matching Investor Opinion
Jun 15Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?
Apr 14Calculating The Intrinsic Value Of AtriCure, Inc. (NASDAQ:ATRC)
Mar 02What Does AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Indicate?
Feb 09Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?
Dec 28Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?
Sep 06An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued
Aug 02AtriCure: 5x Sales For A Series Of Impeding Losses? No Thanks
Jun 13Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?
Jun 08Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?
May 08Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$40m |
| Mar 31 2024 | n/a | n/a | -US$37m |
| Dec 31 2023 | US$9m | US$804k | -US$30m |
| Sep 30 2023 | n/a | n/a | -US$25m |
| Jun 30 2023 | n/a | n/a | -US$28m |
| Mar 31 2023 | n/a | n/a | -US$38m |
| Dec 31 2022 | US$8m | US$795k | -US$46m |
| Sep 30 2022 | n/a | n/a | -US$56m |
| Jun 30 2022 | n/a | n/a | US$53m |
| Mar 31 2022 | n/a | n/a | US$52m |
| Dec 31 2021 | US$8m | US$766k | US$50m |
| Sep 30 2021 | n/a | n/a | US$45m |
| Jun 30 2021 | n/a | n/a | -US$57m |
| Mar 31 2021 | n/a | n/a | -US$49m |
| Dec 31 2020 | US$6m | US$718k | -US$48m |
| Sep 30 2020 | n/a | n/a | -US$46m |
| Jun 30 2020 | n/a | n/a | -US$50m |
| Mar 31 2020 | n/a | n/a | -US$46m |
| Dec 31 2019 | US$6m | US$740k | -US$35m |
| Sep 30 2019 | n/a | n/a | -US$23m |
| Jun 30 2019 | n/a | n/a | -US$20m |
| Mar 31 2019 | n/a | n/a | -US$17m |
| Dec 31 2018 | US$4m | US$714k | -US$21m |
| Sep 30 2018 | n/a | n/a | -US$20m |
| Jun 30 2018 | n/a | n/a | -US$20m |
| Mar 31 2018 | n/a | n/a | -US$27m |
| Dec 31 2017 | US$4m | US$671k | -US$27m |
Compensatie versus markt: De totale vergoeding ($USD 8.75M ) Mike } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.54M ).
Compensatie versus inkomsten: De vergoeding van Mike is gestegen terwijl het bedrijf verliesgevend is.
CEO
Mike Carrel (53 yo)
11.9yrs
Tenure
US$8,749,289
Compensatie
Mr. Michael H. Carrel, also known as Mike, serves as the Chief Executive Officer and President at AtriCure, Inc. since November 2012. Mr. Carrel has been Director at Axonics Inc. since February 27, 2019 an...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 11.9yrs | US$8.75m | 1.36% $ 18.3m | |
| Chief Financial Officer | 4.2yrs | US$2.92m | 0.29% $ 3.8m | |
| Chief Operating Officer | 9.8yrs | US$3.50m | 0.32% $ 4.3m | |
| Chief Technical Officer | 7.8yrs | US$2.13m | 0.21% $ 2.9m | |
| Chief Legal Officer | 5.6yrs | US$2.13m | 0.11% $ 1.4m | |
| Chief Scientific Officer | 7.6yrs | US$1.78m | 0.12% $ 1.7m | |
| Vice President of Corporate Marketing & Communications | no data | geen gegevens | geen gegevens | |
| Chief Marketing & Strategy Officer | 8.6yrs | US$1.78m | 0.15% $ 2.0m | |
| Chief Human Resources Officer | 2.3yrs | US$1.92m | 0.098% $ 1.3m |
7.7yrs
Gemiddelde duur
53yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van ATRC is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 11.9yrs | US$8.75m | 1.36% $ 18.3m | |
| Independent Director | 7.9yrs | US$227.47k | 0.059% $ 800.6k | |
| Independent Director | 7.6yrs | US$264.97k | 0.091% $ 1.2m | |
| Independent Director | less than a year | geen gegevens | 0.027% $ 362.2k | |
| Independent Chairman of the Board | 11.6yrs | US$225.47k | 0.20% $ 2.7m | |
| Independent Director | 4.8yrs | US$219.97k | 0.049% $ 661.2k | |
| Independent Director | 3.3yrs | US$209.97k | 0.018% $ 247.8k | |
| Independent Director | 7.6yrs | US$232.47k | 0.063% $ 850.1k | |
| Independent Director | 3.3yrs | US$212.47k | 0.034% $ 463.7k |
7.6yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van ATRC wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.6 jaar).